Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2025 Filed Jun 2, 2025 20:12 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Converted) · Derivative | 3,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000121 · wk-form4_1748895124.xml · derivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,089 Underlying: Common Stock · 3,089 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 772 shares vested on May 29, 2025, 772 shares will vest on August 29, 2025, 772 shares will vest on November 29, 2025 and 773 shares will vest on February 28, 2026. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 772 shares vested on May 29, 2025, 772 shares will vest on August 29, 2025, 772 shares will vest on November 29, 2025 and 773 shares will vest on February 28, 2026. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:12 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000121 · wk-form4_1748895124.xml · derivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,829 Underlying: Common Stock · 6,829 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on May 29, 2026. F2 · derivative.expiration_date: The restricted stock units will vest on May 29, 2026. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:21 UTC |
Wilkins Joseph D Jr.Director
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000125 · wk-form4_1748895704.xml · derivative · entry 1 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,829 Underlying: Common Stock · 6,829 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on May 29, 2026. F2 · derivative.expiration_date: The restricted stock units will vest on May 29, 2026. Read SEC document |
| May 29, 2025 Filed Jun 3, 2025 20:08 UTC Amendment |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000135 · wk-form4a_1748981286.xml · derivative · entry 3 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325 Underlying: Common Stock · 325 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on May 29, 2026. F4 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on May 29, 2026. F4 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 29, 2025 Filed Jun 3, 2025 20:08 UTC Amendment |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000135 · wk-form4a_1748981286.xml · derivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,626 Underlying: Common Stock · 1,626 shares Expires not disclosed F3 · security: The Form 4 originally filed on June 2, 2025 is being amended to report the correct vesting dates for the converted restricted stock units granted to the reporting person on May 29, 2025. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F5 · derivative.exercise_date: 406 shares vested on May 29, 2025, 406 shares will vest on August 29, 2025, 407 shares will vest on November 29, 2025 and 407 shares will vest on February 28, 2026. F4 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F5 · derivative.expiration_date: 406 shares vested on May 29, 2025, 406 shares will vest on August 29, 2025, 407 shares will vest on November 29, 2025 and 407 shares will vest on February 28, 2026. Read SEC document |
| May 29, 2025 Filed Jun 3, 2025 20:08 UTC Amendment |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000135 · wk-form4a_1748981286.xml · derivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,829 Underlying: Common Stock · 6,829 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on May 29, 2026. F2 · derivative.expiration_date: The restricted stock units will vest on May 29, 2026. Read SEC document |
| May 25, 2025 Filed May 28, 2025 20:13 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000107 · wk-form4_1748463190.xml · derivative · entry 3 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 420 shares vested on May 25, 2025. F4 · derivative.expiration_date: 420 shares vested on May 25, 2025. Read SEC document |
| May 25, 2025 Filed May 28, 2025 20:13 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 151 | $29.74 | $4,490.74 |
DisclosureSEC source: 0001906324-25-000107 · wk-form4_1748463190.xml · nonDerivative · entry 2 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,506 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 25, 2025 Filed May 28, 2025 20:13 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000107 · wk-form4_1748463190.xml · nonDerivative · entry 1 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,657 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| May 25, 2025 Filed May 28, 2025 16:15 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000108 · wk-form4_1748463345.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 420 shares vested on May 25, 2025. F4 · derivative.expiration_date: 420 shares vested on May 25, 2025. Read SEC document |
| May 25, 2025 Filed May 28, 2025 16:15 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 214 | $29.74 | $6,364.36 |
DisclosureSEC source: 0001906324-25-000108 · wk-form4_1748463345.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,369 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 25, 2025 Filed May 28, 2025 16:15 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000108 · wk-form4_1748463345.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,583 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 24, 2025 Filed May 28, 2025 20:19 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000110 · wk-form4_1748463542.xml · derivative · entry 4 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 24, 2025 Filed May 28, 2025 20:19 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000110 · wk-form4_1748463542.xml · derivative · entry 3 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 546 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 24, 2025 Filed May 28, 2025 20:19 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000110 · wk-form4_1748463542.xml · nonDerivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,271 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 24, 2025 Filed May 28, 2025 20:19 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000110 · wk-form4_1748463542.xml · nonDerivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,162 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 24, 2025 Filed May 28, 2025 20:17 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000109 · wk-form4_1748463429.xml · derivative · entry 4 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 24, 2025 Filed May 28, 2025 20:17 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000109 · wk-form4_1748463429.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 402 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 24, 2025 Filed May 28, 2025 20:17 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000109 · wk-form4_1748463429.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,624 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 24, 2025 Filed May 28, 2025 20:17 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000109 · wk-form4_1748463429.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,544 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:30 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000100 · wk-form4_1748377816.xml · derivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:30 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000100 · wk-form4_1748377816.xml · nonDerivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,066 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:16 UTC |
Chiminski John RDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000093 · wk-form4_1748376971.xml · derivative · entry 2 Chiminski John R · CIK 0001482197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:16 UTC |
Chiminski John RDirector
|
GrantCommon Stock | 2,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000093 · wk-form4_1748376971.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,523 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:14 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000092 · wk-form4_1748376844.xml · derivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:14 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000092 · wk-form4_1748376844.xml · nonDerivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,706 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:24 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000097 · wk-form4_1748377492.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:24 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000097 · wk-form4_1748377492.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,640 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:26 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000098 · wk-form4_1748377595.xml · derivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:26 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000098 · wk-form4_1748377595.xml · nonDerivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,616 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:21 UTC |
Huennekens R ScottDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000095 · wk-form4_1748377266.xml · derivative · entry 2 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:21 UTC |
Huennekens R ScottDirector
|
GrantCommon Stock | 2,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000095 · wk-form4_1748377266.xml · nonDerivative · entry 1 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,523 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:28 UTC |
Strobeck MatthewDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000099 · wk-form4_1748377717.xml · derivative · entry 4 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F5 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:28 UTC |
Strobeck MatthewDirector
|
GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000099 · wk-form4_1748377717.xml · nonDerivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,775 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:22 UTC |
Michael Edward L.Director
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000096 · wk-form4_1748377370.xml · derivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:22 UTC |
Michael Edward L.Director
|
GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000096 · wk-form4_1748377370.xml · nonDerivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,352 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:19 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000094 · wk-form4_1748377166.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:19 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000094 · wk-form4_1748377166.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,142 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:32 UTC |
Wilkins Joseph D Jr.Director
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000101 · wk-form4_1748377916.xml · derivative · entry 2 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2025. F3 · derivative.expiration_date: The restricted stock units vested on May 22, 2025. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:32 UTC |
Wilkins Joseph D Jr.Director
|
GrantCommon Stock | 4,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000101 · wk-form4_1748377916.xml · nonDerivative · entry 1 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,506 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:22 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 153 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000074 · wk-form4_1747776149.xml · derivative · entry 4 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 153 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:22 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000074 · wk-form4_1747776149.xml · derivative · entry 3 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 512 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:22 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 153 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000074 · wk-form4_1747776149.xml · nonDerivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,137 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:22 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000074 · wk-form4_1747776149.xml · nonDerivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,984 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:23 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 236 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000075 · wk-form4_1747776196.xml · derivative · entry 4 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:23 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 789 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000075 · wk-form4_1747776196.xml · derivative · entry 3 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:23 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 236 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000075 · wk-form4_1747776196.xml · nonDerivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,777 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:23 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 789 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000075 · wk-form4_1747776196.xml · nonDerivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,541 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:08 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000073 · wk-form4_1747775295.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 128 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employees and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employees and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:08 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000073 · wk-form4_1747775295.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employees and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employees and occurred according to the elected deferred schedule. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.